Dataset Information

Partisanship, Messaging, and the COVID-19 Vaccine: Evidence From Survey Experiments.

ABSTRACT:

Purpose

To investigate partisanship in COVID-19 attitudes, and assess partisan or scientific messaging effects on COVID-19 vaccination intentions.

Design

Two-wave survey with two-arm randomized experiment.

Setting

Recruited Pennsylvania residents online.

Sample

2037 (May 2020) and 1577 (October 2020) Pennsylvania residents, aged 18-94 years.

Intervention

Respondents saw messaging that presented either President Trump or scientists endorsing the vaccine, then reported their vaccination intentions.

Measures

Likert scale items measuring COVID-19 attitudes (May), including mask wearing and vaccination intentions (May and October).

Analysis

Partisan differences in attitudes were analyzed by chi-square; differences in support for mask wearing and vaccination intentions were also analyzed by Mann-Whitney U. The messaging experiment was analyzed by chi-square, Mann-Whitney U, and survey-weighted multivariate logistic regression.

Results

Significant partisan differences were found in all attitudes. The partisan split in support for mask wearing increased from May to October, whereas the split in vaccination intentions decreased. Compared to partisan messaging, scientific messaging increased overall odds of intending to vaccinate by 32% in May (adjusted odds ratio [AOR]=1.32, 95% confidence interval [CI] = 1.06-1.65), and increased odds among Democrats by 142% in October (AOR = 2.42, CI = 1.29-4.55). Scientific messaging had no significant effect on independents or Republicans.

Conclusion

Partisan COVID-19 attitudes were widespread and persistent. Partisan endorsement of the vaccine positively influenced those with congruent beliefs, while scientific messaging produced consistent effects across political affiliation.

SUBMITTER: Golos AM

PROVIDER: S-EPMC8891905 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Partisanship, Messaging, and the COVID-19 Vaccine: Evidence From Survey Experiments.

Golos Aleksandra M AM Hopkins Daniel J DJ Bhanot Syon P SP Buttenheim Alison M AM

American journal of health promotion : AJHP 20220301 4

<h4>Purpose</h4>To investigate partisanship in COVID-19 attitudes, and assess partisan or scientific messaging effects on COVID-19 vaccination intentions.<h4>Design</h4>Two-wave survey with two-arm randomized experiment.<h4>Setting</h4>Recruited Pennsylvania residents online.<h4>Sample</h4>2037 (May 2020) and 1577 (October 2020) Pennsylvania residents, aged 18-94 years.<h4>Intervention</h4>Respondents saw messaging that presented either President Trump or scientists endorsing the vaccine, then r ...[more]

PMID: 35232232

Similar Datasets

Project description:In the last two years, the coronavirus disease 19 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a scientific and social challenge worldwide. Vaccines have been the most effective intervention for reducing virus transmission and disease severity. However, virus genetic variants are still circulating among vaccinated individuals with different symptomatology disease cases. Understanding the protective or disease associated mechanisms in vaccinated individuals is relevant to advance in vaccine development and implementation. To address this objective, serum protein profiles were characterized by quantitative proteomics and data analysis algorithms in four cohorts of vaccinated individuals uninfected and SARS-CoV-2 infected with asymptomatic, nonsevere and severe disease symptomatology. The results showed that immunoglobulins were the most overrepresented proteins in infected cohorts when compared to PCR-negative individuals. The immunoglobulin profile varied between different infected cohorts and correlated with protective or disease associated capacity. Overrepresented immunoglobulins in PCR-positive individuals correlated with protective response against SARS-CoV-2, other viruses, and thrombosis in asymptomatic cases. In nonsevere cases, correlates of protection against SARS-CoV-2 and HBV together with risk of myasthenia gravis and allergy and autoantibodies were observed. Patients with severe symptoms presented risk for allergy, chronic idiopathic thrombocytopenic purpura, and autoantibodies. The analysis of underrepresented immunoglobulins in PCR-positive compared to PCR-negative individuals identified vaccine-induced protective epitopes in various coronavirus proteins including the Spike receptor-binding domain RBD. Non-immunoglobulin proteins were associated with COVID-19 symptoms and biological processes. These results evidence host-associated differences in response to vaccination and the possibility of improving vaccine efficacy against SARS-CoV-2.

Project description:BackgroundCOVID-19 vaccination efforts are lagging in Sub-Saharan Africa, as just over 20 percent of the population has been fully vaccinated. COVID-19 vaccine hesitancy is considered important as a prerequisite for widespread vaccine take-up. Here, we study the dynamics of vaccine acceptance, its correlates, and reasons for hesitancy over time, drawing on two years of panel survey data.MethodsIn this observational study, we use multiple rounds of data from national High Frequency Phone Surveys (HFPS) in five countries in East and West Africa (Burkina Faso, Ethiopia, Malawi, Nigeria, and Uganda), covering a period between 2020 and 2022. The surveys are cross-country comparable and draw their samples from nationally representative sampling frames. Based on this data source, the study presents population-weighted means and performs multivariate regression analysis.ResultsCOVID-19 vaccine acceptance was high throughout the study period (68% to 98%). However, acceptance levels were lower in 2022 than in 2020 in three countries (Burkina Faso, Malawi, Nigeria), and higher in one country (Uganda). Moreover, individuals are observed to change their stated vaccine attitudes between survey rounds, to a limited extent in some countries (Ethiopia) and more frequently in others (Burkina Faso, Malawi, Nigeria, Uganda). Vaccine hesitancy is higher in richer households, and those residing in urban areas; among women and those better educated. Hesitancy is lower in larger households and among heads of the household. The main reasons for hesitancy are concerns about side effects of the vaccine, its safety and efficacy, as well as assessments of COVID-19 risk, though these reasons fluctuate over time.ConclusionsReported COVID-19 vaccine acceptance levels remain far above vaccination rates in the study countries, suggesting that vaccine hesitancy is not the primary obstacle to reaching greater vaccine coverage, which may instead be related to access and delivery barriers as well as supply shortages. Nevertheless, vaccine attitudes appear malleable so that continued efforts are needed to retain high levels of vaccine acceptance.

Dataset Information

Partisanship, Messaging, and the COVID-19 Vaccine: Evidence From Survey Experiments.

Purpose

Design

Setting

Sample

Intervention

Measures

Analysis

Results

Conclusion

Publications

Partisanship, Messaging, and the COVID-19 Vaccine: Evidence From Survey Experiments.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets